Biblio Discovery — Demo Discovery Service

4 hasil untuk "Feng-Feng Ping"

Menampilkan 1–4 · 2,80 detik · RSS

  1. Artikel Jurnal Teks lengkap

    An Impact of COVID-19 on Cancer Care: An Update

    Vivek P. Chavda; Feng-Feng Ping; Zhe-Sheng Chen

    Vaccines, Vol. 10 No. 12 · 2022 · Inggris · DOAJ Scopus

    The world has been affected socioeconomically for the last two years due to the emergence of different variants of the COVID-19 virus. Vaccination is the major and most efficient way to prevent the widening of this pandemic. Those who are having comorbidities are more vulnerable to serious…

  2. Artikel Jurnal

    Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells

    Zi‐Ning Lei; Qiu‐Xu Teng; Zhuo‐Xun Wu dkk.

    MedComm, Vol. 2 No. 4 · 2021 · Inggris · DOAJ Scopus

    Abstract Multidrug resistance (MDR) has been extensively reported in colorectal cancer patients, which remains a major cause of chemotherapy failure. One of the critical mechanisms of MDR in colorectal cancer is the reduced intracellular drug level led by the upregulated expression of the…

  3. Artikel Jurnal

    Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An in vitro and in vivo study

    Silpa Narayanan; Qiu-Xu Teng; Zhuo-Xun Wu dkk.

    Frontiers in Oncology, Vol. 12 · 2022 · Inggris · DOAJ Scopus

    Colorectal cancer is a major health problem, and it is the third most diagnosed cancer in the United States. The current treatment for colorectal cancer includes irinotecan, a topoisomerase I inhibitor, and other targeted drugs, such as bevacizumab and regorafenib. The low response rates and…

  4. Artikel Jurnal

    Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells

    Lei Zhang; Biwei Ye; Yunfeng Lin dkk.

    Frontiers in Pharmacology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    The efficacy of cancer chemotherapy can be attenuated or abrogated by multidrug resistance (MDR) in cancer cells. In this study, we determined the effect of the CDK4/6 inhibitor, ribociclib (or LEE011), on P-glycoprotein (P-gp)-mediated MDR in the human epidermoid carcinoma MDR cell line, KB-C2…